Follow
Horst Kessler
Horst Kessler
Unknown affiliation
Verified email at tum.de
Title
Cited by
Cited by
Year
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
U Hersel, C Dahmen, H Kessler
Biomaterials 24 (24), 4385-4415, 2003
31532003
Activation of integrin function by nanopatterned adhesive interfaces
M Arnold, EA Cavalcanti‐Adam, R Glass, J Blümmel, W Eck, ...
ChemPhysChem 5 (3), 383-388, 2004
13702004
Conformation and biological activity of cyclic peptides
H Kessler
Angewandte Chemie International Edition in English 21 (7), 512-523, 1982
11461982
Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands
EA Cavalcanti-Adam, T Volberg, A Micoulet, H Kessler, B Geiger, ...
Biophysical journal 92 (8), 2964-2974, 2007
10842007
N-Methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists
MA Dechantsreiter, E Planker, B Mathä, E Lohof, G Hölzemann, ...
Journal of medicinal chemistry 42 (16), 3033-3040, 1999
10381999
Assignment of carbonyl carbons and sequence analysis in peptides by heteronuclear shift correlation via small coupling constants with broadband decoupling in t1 (COLOC)
H Kessler, C Griesinger, J Zarbock, HR Loosli
Journal of Magnetic Resonance (1969) 57 (2), 331-336, 1984
8161984
Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin αvβ3 antagonists
R Haubner, R Gratias, B Diefenbach, SL Goodman, A Jonczyk, H Kessler
Journal of the American chemical society 118 (32), 7461-7472, 1996
8141996
Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography
R Haubner, HJ Wester, WA Weber, C Mang, SI Ziegler, SL Goodman, ...
Cancer research 61 (5), 1781-1785, 2001
8082001
Arg-Gly-Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1
M Aumailley, M Gurrath, G Müller, J Calvete, R Timpl, H Kessler
FEBS letters 291 (1), 50-54, 1991
7481991
Cilengitide: the first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation
C Mas-Moruno, F Rechenmacher, H Kessler
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2010
7362010
Detection of hindered rotation and inversion by NMR spectroscopy
H Kessler
Angewandte Chemie International Edition in English 9 (3), 219-235, 1970
7311970
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins.
M Pfaff, K Tangemann, B Müller, M Gurrath, G Müller, H Kessler, R Timpl, ...
Journal of Biological Chemistry 269 (32), 20233-20238, 1994
6711994
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics
R Haubner, HJ Wester, F Burkhart, R Senekowitsch-Schmidtke, W Weber, ...
Journal of Nuclear Medicine 42 (2), 326-336, 2001
6422001
N-methylation of peptides: a new perspective in medicinal chemistry
J Chatterjee, C Gilon, A Hoffman, H Kessler
Accounts of chemical research 41 (10), 1331-1342, 2008
6372008
Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD
R Haubner, WA Weber, AJ Beer, E Vabuliene, D Reim, M Sarbia, ...
PLoS medicine 2 (3), e70, 2005
6252005
Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer Therapy
R Haubner, D Finsinger, H Kessler
Angewandte Chemie International Edition in English 36 (13‐14), 1374-1389, 1997
5921997
Two‐Dimensional NMR Spectroscopy: Background and Overview of the Experiments [New Analytical Methods (36)]
H Kessler, M Gehrke, C Griesinger
Angewandte Chemie International Edition in English 27 (4), 490-536, 1988
5821988
Impact of order and disorder in RGD nanopatterns on cell adhesion
J Huang, SV Grater, F Corbellini, S Rinck, E Bock, R Kemkemer, ...
Nano letters 9 (3), 1111-1116, 2009
5782009
Radiolabeled αvβ3 integrin antagonists: a new class of tracers for tumor targeting
R Haubner, HJ Wester, U Reuning, R Senekowitsch-Schmidtke, ...
Journal of Nuclear Medicine 40 (6), 1061-1071, 1999
5731999
Carbohydrate-based mimetics in drug design: sugar amino acids and carbohydrate scaffolds
SAW Gruner, E Locardi, E Lohof, H Kessler
Chemical reviews 102 (2), 491-514, 2002
5552002
The system can't perform the operation now. Try again later.
Articles 1–20